Cargando…
Peripheral Tumor Location Predicts a Favorable Prognosis in Patients with Resected Small Cell Lung Cancer
BACKGROUND: Small cell lung cancer (SCLC) is an aggressive malignancy. Surgical resection is currently only recommended for clinical stage I patients who have been carefully staged. The clinical outcomes of patients with resected SCLCs vary because the disease is highly heterogeneous, suggesting tha...
Autores principales: | Gao, Yina, Dong, Yangyang, Zhou, Yingxu, Chen, Gongyan, Hong, Xuan, Zhang, Qingyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718634/ https://www.ncbi.nlm.nih.gov/pubmed/36605462 http://dx.doi.org/10.1155/2022/4183326 |
Ejemplares similares
-
Clinical Characteristics Correlate With Outcomes of Immunotherapy in Advanced Non-Small Cell Lung Cancer
por: Huang, Lan, et al.
Publicado: (2020) -
Regional emphysema score is associated with tumor location and poor prognosis in completely resected NSCLC patients
por: Heo, Jung Won, et al.
Publicado: (2020) -
Heterogeneous distribution pattern of CD3+ tumor-infiltrated lymphocytes (TILs) and high combined positive score (CPS) favored the prognosis of resected early stage small-cell lung cancer
por: Zhu, Liang, et al.
Publicado: (2023) -
High BMI1 mRNA expression in peripheral whole blood is associated with favorable prognosis in advanced non-small cell lung cancer patients
por: Koren, Ana, et al.
Publicado: (2017) -
Nodal involvement pattern in resectable lung cancer according to tumor location
por: Saeteng, Somcharoen, et al.
Publicado: (2012)